Skip to content
    Fountain Healthcare Partners logo

    Fountain Healthcare Partners

    Dublin, IrelandFounded 2008
    www.fh-partners.comLinkedIn
    Biotech & Life SciencesHealthcare

    Fountain Healthcare Partners is a life science venture capital firm based in Dublin with an office in New York. Founded in 2008, it provides risk capital and expertise to entrepreneurs building specialty pharma, biopharmaceutical, medical device, and diagnostics companies across Europe and the United States.

    Deal activity decreased year-over-year (2 deals in the last 12 months vs 4 prior). Average disclosed round size is $51.4M (across 21 rounds with reported amounts).

    Find people at Fountain Healthcare Partners on Goldilocks AI

    Portfolio

    32

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    2

    Team

    AK

    Aidan King, MBA, CFA

    Managing Partner & Co-Founder

    DM

    Dr. Manus Rogan, Ph.D, MBA

    Managing Partner & Co-Founder

    JL

    Justin Lynch, MBA

    Partner

    RM

    Ruthanne Monaghan, FCCA

    Partner & CFO

    CT

    Chris Tapper

    Senior Associate

    AF

    Annie Flynn, FCA

    Financial Controller

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    41 investments
    CompanyRoundAmountDate
    Neurent Medical logoNeurent MedicalSeries C$74MFeb 2026
    Exciva logoExcivaSeries B—Jan 2026
    NEUROMOD DEVICES LTD logoNEUROMOD DEVICES LTDSeries B—Mar 2025
    Exciva logoExcivaSeries B$59MJan 2025
    Xylocor logoXylocorSeries B$67.5MJan 2025
    XyloCor Therapeutics logoXyloCor TherapeuticsSeries B$67.5MJan 2025
    MMedical MicroinstrumentsSeries C$110MFeb 2024
    MMedical MicroinstrumentsSeries C$110MJan 2024
    Dualyx logoDualyxSeries A$44MMay 2023
    Neuromod logoNeuromodSeries B—Apr 2023
    CCorteriaSeries A—Jan 2023
    NeRRe Therapeutics logoNeRRe TherapeuticsUnknown—Jul 2021
    PPriothera Ltd.Series A—Oct 2020
    IInotremSeries B—Sep 2020
    Inflazome logoInflazomeSeries B—Nov 2018
    KKaNDy TherapeuticsSeries C$32.5MAug 2018
    NNEURENT MEDICAL LIMITEDSeries A—May 2018
    NeRRe Therapeutics logoNeRRe TherapeuticsSeries B—Jan 2017
    Chrono logoChronoSeries B$47.6MSep 2016
    CChrono TherapeuticsSeries B$47.6MSep 2016
    CChrono TherapeuticsUnknown$47.6MJan 2016
    GGenableUnknown—Jan 2014
    Trino Therapeutics logoTrino TherapeuticsSeries A—May 2013
    Opsona logoOpsonaSeries C—Apr 2013
    OOpsona TherapeuticsSeries C—Apr 2013
    Page 1 of 2

    Top Co-Investors

    EQT Life Sciences6 shared
    OrbiMed6 shared
    Enterprise Ireland5 shared
    Andera Partners5 shared
    Forbion5 shared
    Sofinnova Partners4 shared
    Jeito Capital4 shared
    Kurma Partners4 shared
    Longitude Capital4 shared
    Canaan Partners4 shared
    Roche Venture Fund4 shared
    Sunstone Life Science Ventures4 shared
    Amgen Ventures4 shared
    Asahi Kasei3 shared
    Cota Capital3 shared
    Kaiser Permanente Ventures3 shared
    Emergent Medical Partners3 shared
    Mayo Clinic Ventures3 shared
    Endeavour Vision3 shared
    Atlantic Bridge2 shared

    Last updated: 8 September 2026